Nevro Corp. (NVRO)
NYSE: NVRO · Real-Time Price · USD
5.01
-0.12 (-2.34%)
Feb 5, 2025, 3:29 PM EST - Market open
Nevro Employees
Nevro had 1,215 employees as of December 31, 2023. The number of employees increased by 128 or 11.78% compared to the previous year.
Employees
1,215
Change (1Y)
128
Growth (1Y)
11.78%
Revenue / Employee
$344,976
Profits / Employee
-$57,044
Market Cap
187.73M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
NVRO News
- 14 days ago - Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - PRNewsWire
- 23 days ago - Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results - PRNewsWire
- 2 months ago - Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos - Benzinga
- 2 months ago - New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches - PRNewsWire
- 3 months ago - Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally - PRNewsWire
- 3 months ago - Nevro Corp. (NVRO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Nevro Reports Third-Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy - PRNewsWire